Assertion on new ways to progress agency’s continued evaluation of prospective regulatory pathways for cannabis-that contains and cannabis-derived productsWell being CBD Advertiser Disclosure The Forbes Health editorial team is unbiased and goal. To help aid our reporting do the job, and to continue our capability to provide this information with